These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt, with results||2007-004819-54||A phase I/II, open label, escalating dose, pilot study to assess the effect, safety, tolerability and pharmacokinetics of multiple subcutaneous doses of drisapersen in patients with Duchenne muscular ...||2016-09-09||not-yet-due|
|Exempt, with results||2009-013762-63||A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability and pharmacokinetics of multiple subcutaneous and intravenous doses of PRO044 in patients with Duchen...||2013-07-30||not-yet-due|
|Exempt, with results||2011-005040-10||A phase IIb, open-label study to assess the efficacy, safety, pharmacodynamics and pharmacokinetics of multiple doses of BMN 045 (previously known as PRO045) in subjects with Duchenne muscular dystrop...||2016-09-09||not-yet-due|
|Listed as ongoing, but also has a completion date and reported results||2011-005042-35||A Phase I/II, open-label, dose escalating with 48 week treatment study to assess the safety and tolerability, pharmacokinetics, pharmacodynamics and efficacy of BMN 053 (previously known as PRO053) in...||2016-09-09||bad-data|
|Reported results||2013-003605-26||A phase II, open label, extension study to assess the effect of PRO044 in patients with Duchenne muscular dystrophy||2016-08-05||due-trials|